The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

[2026 update] Interpreting a result that disagrees with the supplier's certificate

This is a generated summary. It shows the 9 most-liked posts from a topic of 129, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
SS
s.stavrianosTL2Member3 Jun 2026#1

On the subject in the title: Interpreting a result that disagrees with the supplier's certificate Working notes rather than a conclusion.

Structured report rather than an opinion, following the format the maintainers asked for.

  • Compound: semaglutide
  • Independent testing: VendorInvestigate
  • Method as reported: reversed-phase HPLC, 280 nm
  • Result: 95.8% area
  • Certificate figure for the same lot: 98.3%

I am not drawing a conclusion about the supplier from one lot and I would ask that nobody else does either. I am adding a data point to a record.

38 likes 2mo
NT
nl_translatorTL2Translator · NL Solution6 Jun 2026#4
d.bramley, post #2: Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had been repeating something I had not checked carefully enough. Go to post

On post #3 — agreed on the reasoning, with one qualification.

PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over time rather than at a point in time.

12 likes in reply to #2 2mo
EN
electrolyte_notesTL2Regular7 Jun 2026#6

Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not establish a pattern.

29 likes 2mo
MV
m.vukovicTL2 Moderator15 Jun 2026#20
r.lundgren, post #7: post #6 is right about the mechanism and I think understates the practical bit. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is usually faster than testing. Go to post

post #19 answers the question as asked. The question underneath it is different.

Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth more than self-selected ones.

32 likes in reply to #7 1mo
B
BDraganovTL2Member25 Jun 2026#42

Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a chromatogram included. Submission is by mail.

33 likes 1mo
ST
sterile_tableTL3Regular1 Jul 2026#57
b.dumitru, post #3: post #2 answers the question as asked. The question underneath it is different. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing about what is in a container. Go to post

Coming back to post #55, because the follow-up matters more than the original answer.

Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies reproducibility but uses the same method.

32 likes in reply to #3 26d
EL
e.lehtinenTL2 Moderator4 Jul 2026#63

Picking up post #60: that is the part I would want checked first.

Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not establish a pattern.

30 likes 24d
JS
j.solbergTL2 Moderator7 Jul 2026#70

On post #66 — agreed on the reasoning, with one qualification.

Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth more than self-selected ones.

29 likes 21d
CW
cohort_watchTL2Member15 Jul 2026#92

post #91 answers the question as asked. The question underneath it is different.

Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies reproducibility but uses the same method.

33 likes 13d

Read the full topic (129 posts)

Moved from Red flags by s.leclerc. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.

Suggested topics

TopicParticipantsRepliesViewsActivity
Aggregate verification data across the directory, with caveats
On the subject in the title: Aggregate verification data across the directory, with caveats Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
JHSCLCJSMS+64 74 4.6k 14h
What a purity-only report leaves out
What a purity-only report leaves out — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the maintainers…
IBREDHBKEF+92 105 4k 8mo
Revisiting: Aggregate verification data across the directory, with caveats
Revisiting: Aggregate verification data across the directory, with caveats — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal,…
PMPMDBAACB+22 26 23k 17mo
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics question, since the…
IRRHMRCBMK+42 46 46k 2mo
Choosing which test to pay for, given a fixed budget
On the subject in the title: Choosing which test to pay for, given a fixed budget Working notes rather than a conclusion. I would like to talk about documentation quality as a signal, separately from product…
REANKRJPK+60 70 49k 3mo

Related topics — sharing the tags Medutest, VendorInvestigate, blind sampling

TopicParticipantsRepliesViewsActivity
Coming back to: Why quantitation is the hard part, not detection
Why quantitation is the hard part, not detection — that is the question, and I have not found it answered plainly anywhere I have looked. Posting the method first, because I know what the first three replies…
SCNGDBFE+86 92 54k 8mo
One lot is one lot: when a report becomes a pattern
Posting this under the heading it deserves: One lot is one lot: when a report becomes a pattern Everything below is what sits behind that. Structured report rather than an opinion, following the format the…
NCCRM 2 19k 14mo
Interpreting a result that disagrees with the supplier's certificate
Interpreting a result that disagrees with the supplier's certificate Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
SZMJIRHGB+129 153 7.3k 5mo
Chain of custody for a sample you posted yourself
Chain of custody for a sample you posted yourself Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
MRSGPN 2 7.3k 5h
How the vendor documentation pages are maintained, and by whom
How the vendor documentation pages are maintained, and by whom I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to talk about documentation quality as a…
PMFVSL 2 6k 4h